Application Sponsors
ANDA 210133 | PRINSTON PHARMA INC | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
002 | TABLET; ORAL | 5mg | 0 | APIXABAN | APIXABAN |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2022-04-12 | STANDARD |
Submissions Property Types
CDER Filings
PRINSTON PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 210133
[companyName] => PRINSTON PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"2.5mg","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"5mg","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/12\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-04-12
)
)